Common Contracts
3 similar Securities Purchase Agreement contracts by Applied Therapeutics Inc., Stereotaxis, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 24th, 2023 • Applied Therapeutics Inc. • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of April 23, 2023, by and among Applied Therapeutics, Inc., a Delaware corporation, with headquarters located at 545 Fifth Avenue, Suite 1400, New York, NY 10017 (the "Company"), and the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 12th, 2019 • Applied Therapeutics Inc. • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 7, 2019, by and among Applied Therapeutics, Inc., a Delaware corporation, with headquarters located at 545 5th Avenue, Suite 1400, New York, NY 10173 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, an “Initial Buyer” and collectively, the “Initial Buyers”) and any additional buyer that becomes a party to this Agreement in accordance with Section 8(r) hereto, (each an “Additional Buyer” and, collectively, the “Additional Buyers” and together with the Initial Buyers, each a “Buyer” and together, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 8th, 2019 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 7, 2019, by and among Stereotaxis, Inc., a Delaware corporation, with headquarters located at 4320 Forest Park Avenue, Suite 100, St. Louis, MO 63108 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
